INFANRIX hexa susp inj (n ser pré) 10 x 0.5 ml
7680006400047
CH-640
J07CA09
08.08.
1 / 3
google
Details
- Product number
- 0064001
- CPT
- -
- Packaging group
- 10 x 1
- Unit
- Kombipackung(en)
- Composition
- I) DTPa-HepB-IPV: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.2 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80. II) Hib: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, aluminium 0.12 mg ut aluminii phosphas, pro praeparatione. I) et II) corresp. DTPa-HepB-IPV + Hib: toxoidum diphtheriae min. 30 U.I., toxoidum tetani min. 40 U.I., toxoidum pertussis 25 µg, haemagglutininum filamentosum (B. pertussis) 25 µg, pertactinum (B. pertussis) 8 µg, virus poliomyelitis typus 1 inactivatus (Stamm Mahoney) 40 U.I., virus poliomyelitis typus 2 inactivatus (Stamm MEF-1) 8 U.I., virus poliomyelitis typus 3 inactivatus (Stamm Saukett) 32 U.I., hepatitidis B viri antigenum ADNr 10 µg, polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, aluminium 0.32 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.8 mg, medium 199, lactosum, aqua ad iniectabile ad suspensionem pro 0.5 ml, residui: neomycini sulfas, polymyxini B sulfas, formaldehydum, polysorbatum 20, polysorbatum 80.
Articles (1)
Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension
Pulver
10 x 1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
II
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
- | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | Wirkstoff (Principe actif) |
|
12C
|
- | Substance | Wirkstoff (Principe actif) |
|
I
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
0.12 MG | Substance | HBESI |
|
12C
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | HNIDK |
|
12C
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
40.0 UI | Substance | Wirkstoff (Principe actif) |
|
12C
|
40.0 UI | Substance | Wirkstoff (Principe actif) |
|
I
|
8.0 UI | Substance | Wirkstoff (Principe actif) |
|
12C
|
8.0 UI | Substance | Wirkstoff (Principe actif) |
|
I
|
32.0 UI | Substance | Wirkstoff (Principe actif) |
|
12C
|
32.0 UI | Substance | Wirkstoff (Principe actif) |
|
I
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
12C
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
I
|
0.5 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
12C
|
0.5 MG | Substance | HBESI |
|
12C
|
- | Substance | HNIDK |
|
I
|
0.2 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
12C
|
0.32 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
I
|
1.8 MG | Substance | HBESI |
|
12C
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
12C
|
1.8 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
12C
|
- | Substance | HNIDK |
|
I
|
- | Substance | RESI |
|
I
|
- | Substance | RESI |
|
I
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
|
I
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
|
I
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
|
12C
|
- | Substance | RESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 640
- Drug name
- Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension
- Galenic form
- PULSIN
- ATC Code
- J07CA09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/10/2000
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INFANRIX hexa susp inj (n ser pré) 10 x 0.5 ml
- Description (DE)
- INFANRIX hexa Inj Susp (n Fertspr) 10 x 0.5 ml
- Market launch
- 02/10/2000
- Narcotic (BTM)
- No
Application methods
IMU